Qurient Co. Ltd.
- Biotech or pharma, therapeutic R&D
Founded in 2008, Qurient pioneers Korea’s emerging biotech industry with a unique virtual biotech model called ‘Network R&D.’ This approach enables capital efficient innovation across early discovery to clinical development by leveraging a global network of experts in various therapeutic areas.
Qurient focuses on value creation from early research to clinical proof-of-concept, allowing a lean, innovation-driven organization. Qurient believes late stage development is best managed by fully integrated pharmaceutical companies with marketing capabilities.
Qurient’s mission is to deliver innovative therapies that address unmet medical needs, ultimately benefiting patients worldwide and generating lasting value for shareholders.